We hereby wish to inform you that the Board of Directors of the Company at their meeting held today, i.e., February 08, 2024, inter-alia, considered and approved the following: 1. Unaudited Financial Results for the quarter and nine months ended 31st December, 2023 along with the Limited Review Report given by the Statutory Auditors of the Company. 2. The venturing into new business of Industrial Enzymes and Natural Proteins and entering of MoU with the Council of Scientific & Industrial Research (CSIR) under Ministry of Science and Technology, Government of India, LIT University, Nagpur and Hislop College, Nagpur for technology transfer and continuous research and development in this area. The details as per Regulation 30 is as follows: a. Industry or area to which the new line of business belongs to: Biotechnology b. Expected benefits: Sustainability and improved balance sheet c. Estimated amount to be invested: Rs. 10 Crores (Rs. Ten Crores)